Major shareholder announcement – AIM International Mutual Funds
18 März 2024 - 12:28PM
Major shareholder announcement – AIM International Mutual Funds
ANNOUNCEMENT NO. 257
Major shareholder announcement
Major shareholder announcement – AIM
International Mutual Funds
Pursuant to Section 30 of the Danish Capital
Markets Act, it is hereby announced that Invesco Ltd. has informed
ChemoMetec A/S that AIM International Mutual Funds (Invesco
International Mutual Funds) on 13 March 2024, increased its holding
of shares and voting rights to above 5% of the total share capital
and voting rights in ChemoMetec A/S, and that the holding thus
exceeds the 5 per cent limit in section 38 of the Capital Markets
Act.
Additional information
Niels Høy Nielsen, CFOTelephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets
instruments for cell counting and a wide range of other
measurements. ChemoMetec’s instruments are marketed to the
pharmaceutical, biotech and agricultural industries worldwide.
ChemoMetec’s customers include some of the world’s leading
pharmaceutical companies, such as Novartis, Novo Nordisk, H.
Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on
Nasdaq OMX Copenhagen. For more information, go to
www.chemometec.com
Chemometec AS (TG:CHY)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Chemometec AS (TG:CHY)
Historical Stock Chart
Von Jun 2023 bis Jun 2024